Cancer Therapy Current Events | Cancer Therapy News | 9
|
| Page
9 of
145 |
2890 Results |
|
|
|
Sort By:
Page Views | Date |
Scientists Discover Cause Of Leukaemia That Halted Treatment Trial For 'Baby-in-a-Bubble' Syndrome
Medical Research Council (MRC) scientists have helped establish the cause of the leukaemia which developed in two young patients taking part in a pioneering gene therapy trial to treat the fatal 'baby-in-a-bubble' syndrome, severe combined immunodeficiency (X-SCID). The trial at the Necker-Enfants Malades clinic in Paris was stopped last year due... view more... (2003-10-16)
PPARC Media Invite - Fighting Cancer with Physics
PPARC Kite Club Event The Future of Medical Imaging and Radiotherapy 28th April 2005 10.30 am - 5.00 pm (registration from 9.45 am) Institute of Physics, Portland Place, London view more (2005-04-19)
Extra radiation dose prevents breast cancer return in young women
Women 40 years and younger with early-stage breast cancer who receive an additional high dose of radiation (boost dose) after undergoing breast-conserving surgery (lumpectomy) and standard radiation treatment are almost twice as likely to be free of cancer 10 years after treatment compared to those who don't receive the boost dose. view more (2007-10-30)
UCLA researchers identify how antibody blocks prostate cancer growth in animal models
Researchers at UCLA's Jonsson Cancer Center have uncovered the mechanism by which an antibody blocks the growth of prostate cancer in animal models, a discovery that could pave the way for development of a new molecularly targeted therapy. view more (2005-10-18)
First report that apoptotic and anti-angiogenic therapies work better together than alone
American researchers have found that giving a combination of imantanib (Glivec) and a drug that induces cell death (apoptosis) was better at inhibiting the growth of Ewing's sarcoma in mice than either therapy on its own. view more (2006-11-13)
HRT-breast cancer risk stays same, regardless of family history
The risk of developing breast cancer due to taking hormone replacement therapy appears to be the same for women with a family history of the disease and without a family history. view more (2009-05-20)
New Discovery Raises Doubts About Use of Certain Targeted Therapies in Bladder Cancer
Researchers at the University of Virginia Health System have found that one of the genes commonly thought to promote the growth and spread of some types of cancers is in fact beneficial in bladder cancer - a major discovery that could significantly alter the way bladder cancers are treated in the future. view more (2009-03-26)
Drug therapy reduces neuroblastoma tumor growth in pre-clinical investigation
Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Center have discovered a new drug combination that significantly hinders tumor growth in neuroblastoma, a childhood cancer. view more (2009-04-27)
Breast cancer patients turn to reflexology for comfort
Researchers at Michigan State University are finding that many women who are receiving chemotherapy while in the late stages of breast cancer are turning to a complementary therapy known as reflexology to help them cope. view more (2005-10-07)
2-drug combination appears safe and active in metastatic kidney cancer
Fox Chase Cancer Center investigators report that a two-drug blockade of mTOR signaling appears safe in metastatic kidney cancer in a phase I trial. view more (2009-06-01)
Hormone therapy for prostate cancer patients with heart conditions linked to increased death risk
Men with coronary artery disease-induced congestive heart failure or heart attack who receive hormone therapy before or along with radiation therapy for treatment of prostate cancer have an associated increased risk of death. view more (2009-08-26)
Researchers identify new anti-tumor gene
Researchers from Virginia Commonwealth University have identified a new anti-tumor gene called SARI that can interact with and suppress a key protein that is overexpressed in 90 percent of human cancers. The discovery could one day lead to an effective gene therapy for cancer. view more (2008-12-17)
Researchers testing virus-gene therapy combination against melanoma
Researchers at the Moores UCSD Cancer Center are injecting a modified herpes virus into melanoma tumors, hoping to kill the cancer cells while also bolstering the body's immune defenses against the disease. view more (2009-07-02)
New treatment combination proves safe for head and neck cancer patients
Patients undergoing treatment for advanced head and neck cancers may respond well to the addition of gefinitib to chemotherapy. view more (2009-06-01)
Targeted therapy shows significant benefits over standard treatment for advanced kidney cancer
According to a new study, the drug sunitinib malate (Sutent®) is more effective than the current standard cytokine treatment given as an initial therapy for patients with advanced kidney cancer, also known as metastatic renal cell carcinoma (mRCC). view more (2006-06-05)
How can we know early who will benefit from tumor target therapy?
The precise tailoring of tumor target treatment for patients with cancer is an unmet challenge. The goal is to only administer treatments that have a high probability of being effective. view more (2007-11-26)
Risk assessment plays key role in long-term treatment of breast cancer
Breast cancer patients and their physicians may make more informed, long-term treatment decisions using risk assessment strategies to help determine probability of recurrence. view more (2008-08-13)
Fox Chase finds that lung cancer patients respond to erlotinib following cetuximab therapy
Non-small cell lung cancer patients who have progressed on a cetuximab-containing regimen may respond to erlotinib, Fox Chase Cancer Center researchers reported today at the annual meeting of the International Association for the Study of Lung Cancer. view more (2009-08-03)
Cialis improves sexual function for prostate cancer survivors
In the first randomized trial of its kind, Tadalafil, a drug typically prescribed for erectile dysfunction in men, has been proven to increase the sexual function of prostate cancer survivors. view more (2006-10-03)
Promising new treatment option for women with recurrent ovarian cancer
Combining the new drug trabectedin with pegylated liposomal doxorubicin provides clinical benefit to women with relapsed ovarian cancer, according to new results presented at the 33rd Congress of the European Society for Medical Oncology (ESMO) in Stockholm. view more (2008-09-16)
|
|
| Page
9 of
145 |
2890 Results |
|
|
|
Sort By:
Page Views | Date |
|
